1931-7581/asset/MSJ_left.gif?v=1&s=ce812cae8007c4d3128c5c46f9e82db67cc44a8c)
New Drugs and the FDA
Neurotherapeutics in multiple sclerosis: Novel agents and emerging treatment strategies
Article first published online: 23 MAY 2008
DOI: 10.1002/msj.20030
© 2008 Mount Sinai School of Medicine
Issue
Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
Volume 75, Issue 2, pages 157–167, March/April 2008
Additional Information
How to Cite
DeAngelis, T. and Lublin, F. (2008), Neurotherapeutics in multiple sclerosis: Novel agents and emerging treatment strategies. Mt Sinai J Med, 75: 157–167. doi: 10.1002/msj.20030
Publication History
- Issue published online: 23 MAY 2008
- Article first published online: 23 MAY 2008
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!